Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
5.87
+0.09 (1.56%)
Aug 13, 2025, 4:00 PM - Market closed
Apollomics Market Cap
Apollomics has a market cap or net worth of $6.48 million as of August 14, 2025. Its market cap has decreased by -70.49% in one year.
Market Cap
6.48M
Enterprise Value
-2.41M
1-Year Change
-70.49%
Ranking
Category
Stock Price
$5.87
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $6.48M, a decrease of -95.00%. That is a compound annual growth rate of -55.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 6.38M | -40.68% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 576.86B |
| Johnson & Johnson | 415.17B |
| AbbVie | 349.97B |
| UnitedHealth Group | 235.49B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 226.89B |
| Novo Nordisk | 222.88B |